Update on morphea: Part I. Epidemiology, clinical presentation, and pathogenesis

Journal of the American Academy of Dermatology

Volumn 64, Issue 2, 2011, Pages 217-228

  Fett, Nicole ^a   Werth, Victoria P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

autoimmune connective tissue disorder; fibrosing disorders; localized scleroderma; morphea; scleroderma; systemic sclerosis

Indexed keywords

AUTOANTIBODY; COLLAGEN;

ARTHRALGIA; ARTICLE; AUTOIMMUNITY; CLINICAL FEATURE; COLLAGEN SYNTHESIS; CONTINUING EDUCATION; FATIGUE; HUMAN; MALAISE; MEDICAL EDUCATION; MORPHEA; MYALGIA; PATHOGENESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SKIN FIBROSIS; SYSTEMIC SCLEROSIS;

EID: 78751561101     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.05.045     Document Type: Review

References (75)

1. L.S. Peterson, A.M. Nelson, W.P. Su, T. Mason, W.M. O'Fallon, and S.E. Gabriel The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993 J Rheumatol 24 1997 73 80
2. K.J. Murray, and R.M. Laxer Scleroderma in children and adolescents Rheum Dis Clin North Am 28 2002 603 624
3. S. Christen-Zaech, M.D. Hakim, F.S. Afsar, and A.S. Paller Pediatric morphea (localized scleroderma): review of 136 patients J Am Acad Dermatol 59 2008 385 396
4. F. Zulian, B.H. Athreya, R. Laxer, A.M. Nelson, S.K. Feitosa de Oliveira, and M.G. Punaro Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study Rheumatology (Oxford) 45 2006 614 620
5. J.J. Leitenberger, R.L. Cayce, R.W. Haley, B. Adams-Huet, P.R. Bergstresser, and H.T. Jacobe Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases Arch Dermatol 145 2009 545 550
6. A.V. Marzano, S. Menni, A. Parodi, A. Borghi, A. Fuligni, and P. Fabbri Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases Eur J Dermatol 13 2003 171 176
7. L.S. Peterson, A.M. Nelson, and W.P. Su Classification of morphea (localized scleroderma) Mayo Clin Proc 70 1995 1068 1076
8. R.M. Laxer, and F. Zulian Localized scleroderma Curr Opin Rheumatol 18 2006 606 613
9. I. Bielsa, and A. Ariza Deep morphea Semin Cutan Med Surg 26 2007 90 95
10. L. Weibel, and J.I. Harper Linear morphoea follows Blaschko's lines Br J Dermatol 159 2008 175 181
11. M.M. Tollefson, and P.M. Witman En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients J Am Acad Dermatol 56 2007 257 263
12. M. Blaszczyk, L. Krolicki, M. Krasu, O. Glinska, and S. Jablonska Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre J Rheumatol 30 2003 1997 2004
13. L. Orozco-Covarrubias, A. Guzman-Meza, C. Ridaura-Sanz, D. Carrasco Daza, C. Sosa-de-Martinez, and R. Ruiz-Maldonado Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them? J Eur Acad Dermatol Venereol 16 2002 361 366
14. U. Wollina, M. Buslau, B. Heinig, I. Petrov, E. Unger, and E. Kyriopoulou Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma Int J Low Extrem Wounds 6 2007 291 298
15. I. Petrov, M. Gantcheva, L. Miteva, S. Vassileva, and K. Pramatarov Lower lip squamous cell carcinoma in disabling pansclerotic morphea of childhood Pediatr Dermatol 26 2009 59 61
16. S.H. Maragh, M.D. Davis, A.J. Bruce, and A.M. Nelson Disabling pansclerotic morphea: clinical presentation in two adults J Am Acad Dermatol 53 2 suppl. 1 2005 S115 S119
17. M. Matucci-Cerinic, Y. Allanore, L. Czirjak, A. Tyndall, U. Muller-Ladner, and C. Denton The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy Ann Rheum Dis 68 2009 1377 1380
18. S.N. Lambova, and U. Muller-Ladner The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports Rheumatol Int 29 2009 1263 1271
19. G. Spencer-Green Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases Arch Intern Med 158 1998 595 600
20. M. Cutolo, W. Grassi, and M. Matucci Cerinic Raynaud's phenomenon and the role of capillaroscopy Arthritis Rheum 48 2003 3023 3030
21. M.B. Kahaleh Raynaud phenomenon and the vascular disease in scleroderma Curr Opin Rheumatol 16 2004 718 722
22. I. Kister, M. Inglese, R.M. Laxer, and J. Herbert Neurologic manifestations of localized scleroderma: a case report and literature review Neurology 71 2008 1538 1545
23. M.E. Zannin, G. Martini, B.H. Athreya, R. Russo, G. Higgins, and F. Vittadello Ocular involvement in children with localised scleroderma: a multi-centre study Br J Ophthalmol 91 2007 1311 1314
24. B. Kasap, A. Soylu, M. Turkmen, Y. Goktay, S. Sarioglu, and C. Ozturk Juvenile linear scleroderma with unique forms of renal involvement Pediatr Nephrol 24 2009 2041 2045
25. J. Wozniak, R. Dabrowski, D. Luczak, M. Kwiatkowska, E. Musiej-Nowakowska, and I. Kowalik Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma J Rheumatol 36 2009 191 196
26. E.B. Kroft, E.M. de Jong, and A.W. Evers Psychological distress in patients with morphea and eosinophilic fasciitis Arch Dermatol 145 2009 1017 1022
27. N.M. Orzechowski, D.M. Davis, T.G. Mason 3rd, C.S. Crowson, and A.M. Reed Health-related quality of life in children and adolescents with juvenile localized scleroderma Rheumatology (Oxford) 48 2009 670 672
28. A. Torrelo, J. Suarez, I. Colmenero, D. Azorin, A. Perera, and A. Zambrano Deep morphea after vaccination in two young children Pediatr Dermatol 23 2006 484 487
29. J. Ho, Y.H. Rothchild, and R. Sengelmann Vitamin B12-associated localized scleroderma and its treatment Dermatol Surg 30 2004 1252 1255
30. M.S. Guidetti, C. Vincenzi, M. Papi, and A. Tosti Sclerodermatous skin reaction after vitamin K1 injections Contact Dermatitis 31 1994 45 46
31. A. Morell, I. Betlloch, A. Sevila, J. Banuls, and R. Botella Morphea-like reaction from vitamin K1 Int J Dermatol 34 1995 201 202
32. J. Alonso-Llamazares, and I. Ahmed Vitamin K1-induced localized scleroderma (morphea) with linear deposition of IgA in the basement membrane zone J Am Acad Dermatol 38 1998 322 324
33. T. Herrmann, C. Gunther, and P. Csere Localized morphea - a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea Strahlenther Onkol 185 2009 603 607
34. N.R. Bleasel, K.M. Stapleton, C. Commens, and V.A. Ahern Radiation-induced localized scleroderma in breast cancer patients Australas J Dermatol 40 1999 99 102
35. D.A. Davis, P.R. Cohen, M.D. McNeese, and M. Duvic Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma J Am Acad Dermatol 35 1996 923 927
36. B.N. Akay, H. Sanli, and A.O. Heper Postirradiation linear morphoea Clin Exp Dermatol 35 2010 e106 e108
37. J.V. Schaffer, C. Carroll, I. Dvoretsky, M.J. Huether, and M. Girardi Postirradiation morphea of the breast presentation of two cases and review of the literature Dermatology 200 2000 67 71
38. A. Peroni, A. Zini, V. Braga, C. Colato, S. Adami, and G. Girolomoni Drug-induced morphea: report of a case induced by balicatib and review of the literature J Am Acad Dermatol 59 2008 125 129
39. O. Kraigher, S. Brenner, and E. Tur Anti-double-stranded DNA-positive unilateral generalized morphea in an adult, possibly exacerbated by ibuprofen Arch Dermatol 145 2009 844 846
40. E. Asbrink, E. Brehmer-Andersson, and A. Hovmark Acrodermatitis chronica atrophicans - a spirochetosis. Clinical and histopathological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius Am J Dermatopathol 8 1986 209 219
41. K. Eisendle, T. Grabner, and B. Zelger Morphoea: a manifestation of infection with Borrelia species? Br J Dermatol 157 2007 1189 1198
42. F. Espinoza-Leon, M. Hassanhi-Hassanhi, F. Arocha-Sandoval, and M. Urbina-Lopez Absence of Borrelia burgdorferi antibodies in the sera of Venezuelan patients with localized scleroderma (morphea) Invest Clin 47 2006 283 288
43. B. Weide, B. Schittek, T. Klyscz, K. Schuz, M. Stark, and G. Rassner Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction Br J Dermatol 143 2000 780 785
44. M.I. Colome-Grimmer, D.A. Payne, S.K. Tyring, and R.L. Sanchez Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States Arch Dermatol 133 1997 1174
45. J. Alonso-Llamazares, D.H. Persing, P. Anda, L.E. Gibson, B.J. Rutledge, and L. Iglesias No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review Acta Derm Venereol 77 1997 299 304
46. S. Akimoto, O. Ishikawa, and Y. Miyachi The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized scleroderma J Rheumatol 23 1996 573 574
47. J.R. De Vito, A.J. Merogi, T. Vo, E.E. Boh, H.K. Fung, and S.M. Freeman Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases J Cutan Pathol 23 1996 350 358
48. W. Fan, C.L. Leonardi, and N.S. Penneys Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea) J Am Acad Dermatol 33 1995 682 684
49. W.I. Dillon, G.M. Saed, and D.P. Fivenson Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America J Am Acad Dermatol 33 1995 617 620
50. R. Wienecke, E.M. Schlupen, N. Zochling, U. Neubert, M. Meurer, and M. Volkenandt No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma J Invest Dermatol 104 1995 23 26
51. K. Eisendle, T. Grabner, and B. Zelger Focus floating microscopy: "gold standard" for cutaneous borreliosis? Am J Clin Pathol 127 2007 213 222
52. J.C. Prinz, Z. Kutasi, P. Weisenseel, L. Poto, Z. Battyani, and T. Ruzicka "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases J Am Acad Dermatol 60 2009 248 255
53. J.P. Pandey, and E.C. LeRoy Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis Arthritis Rheum 41 1998 10 15
54. M.B. Kahaleh, and E.C. LeRoy Autoimmunity and vascular involvement in systemic sclerosis (SSc) Autoimmunity 31 1999 195 214
55. Y. Arnson, H. Amital, S. Guiducci, M. Matucci-Cerinic, G. Valentini, and O. Barzilai The role of infections in the immunopathogensis of systemic sclerosis - evidence from serological studies Ann N Y Acad Sci 1173 2009 627 632
56. R.C. Lawrence, C.G. Helmick, F.C. Arnett, R.A. Deyo, D.T. Felson, and E.H. Giannini Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States Arthritis Rheum 41 1998 778 799
57. T. Arkachaisri, N. Fertig, S. Pino, and T.A. Medsger Jr. Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study J Rheumatol 35 2008 2439 2444
58. K. Takehara, and S. Sato Localized scleroderma is an autoimmune disorder Rheumatology (Oxford) 44 2005 274 279
59. I. Hayakawa, M. Hasegawa, K. Takehara, and S. Sato Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma Arthritis Rheum 50 2004 227 232
60. T. Matsushita, M. Hasegawa, K. Yanaba, M. Kodera, K. Takehara, and S. Sato Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes Arthritis Rheum 54 2006 192 201 (Pubitemid 43122202)
61. K. Yimane, H. Ihn, M. Kubo, Y. Asano, N. Yazawa, and K. Tamaki Anti-U3 snRNP antibodies in localised scleroderma Ann Rheum Dis 60 2001 1157 1158
62. R. Sgonc, M.S. Gruschwitz, H. Dietrich, H. Recheis, M.E. Gershwin, and G. Wick Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma J Clin Invest 98 1996 785 792
63. N.C. Lambert, J.M. Pang, Z. Yan, T.D. Erickson, A.M. Stevens, and D.E. Furst Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son Ann Rheum Dis 64 2005 845 848
64. J.M. Rak, P.P. Pagni, K. Tiev, Y. Allanore, D. Farge, and J.R. Harle Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset Rheumatology (Oxford) 48 2009 363 366
65. K.T. McNallan, C. Aponte, R. el-Azhary, T. Mason, A.M. Nelson, and J.J. Paat Immunophenotyping of chimeric cells in localized scleroderma Rheumatology (Oxford) 46 2007 398 402
66. P. Helmbold, E. Fiedler, M. Fischer, and W. Marsch Hyperplasia of dermal microvascular pericytes in scleroderma J Cutan Pathol 31 2004 431 440
67. K. Yamane, H. Ihn, M. Kubo, N. Yazawa, K. Kikuchi, and Y. Soma Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma J Am Acad Dermatol 42 2000 64 69 (Pubitemid 30470321)
68. H. Higley, K. Persichitte, S. Chu, W. Waegell, R. Vancheeswaran, and C. Black Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon Arthritis Rheum 37 1994 278 288
69. N. Higashi-Kuwata, T. Makino, Y. Inoue, M. Takeya, and H. Ihn Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma Exp Dermatol 18 2009 727 729
70. T. Yamamoto Chemokines and chemokine receptors in scleroderma Int Arch Allergy Immunol 140 2006 345 356
71. Y. Asano, H. Ihn, M. Jinnin, Y. Mimura, and K. Tamaki Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma J Invest Dermatol 126 2006 1761 1769
72. S. Tomimura, F. Ogawa, Y. Iwata, K. Komura, T. Hara, and E. Muroi Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma J Dermatol Sci 52 2008 47 54
73. S. Liu, M. Kapoor, X. Shi-wen, L. Kennedy, C.P. Denton, and M. Glogauer Role of Rac1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac1-knockout mice Arthritis Rheum 58 2008 2189 2195
74. M.M. Fawzi, S.O. Tawfik, A.M. Eissa, M.H. El-Komy, M.R. Abdel-Halim, and O.G. Shaker Expression of insulin-like growth factor-I in lesional and non-lesional skin of patients with morphoea Br J Dermatol 159 2008 86 90
75. A. Milano, S.A. Pendergrass, J.L. Sargent, L.K. George, T.H. McCalmont, and M.K. Connolly Molecular subsets in the gene expression signatures of scleroderma skin PLoS One 3 2008 e2696